Pharmaceutical products | Tenderlake

Pharmaceutical products

Contract Value:
-
Notice Type:
Contract Notice
Published Date:
11 July 2023
Closing Date:
28 August 2023
Location(s):
BE1 RÉGION DE BRUXELLES-CAPITALE/BRUSSELS HOOFDSTEDELIJK GEWEST (BE Belgium/BELGIQUE-BELGIË)
Description:
Framework agreement for the purchase of deferasirox and octreotide (patents released)

See II.1.1

deferasirox

See II.2.1

Octreotide kortwerkend 0,1mg

See II.2.1

Octreotide kortwerkend 0,5mg

See II.2.1

Octreotide langwerkend 20mg en 30mg

See II.2.1

Download full details as .pdf
The Buyer:
Universitair Ziekenhuis Brussel
CPV Code(s):
33600000 - Pharmaceutical products
33690000 - Various medicinal products